DS-6930 is a potent and selective agonist of PPARgamma, with an EC50 of 41 nM. DS-6930 could robust reduce plasma glucose (PG), and with fewer PPARgamma-related adverse effects than Rosiglitazone. DS-6930 can be used for the research of diabetes[1].
Molecular Weight:
403.43
CAS Number:
[1242328-82-0]
Formula:
C23H21N3O4
Target:
PPAR
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
